How does reagent-rental pricing compare to outright instrument purchase for mid-size hospitals?

Reagent-rental eliminates USD 0.8–1.2 million upfront capital by bundling analyzer placement with multi-year consumable contracts. Per-test costs run 10–15% higher than ownership models, but total cost of ownership often favors rental when maintenance is included [12]. Read More

What cybersecurity risks do connected blood-bank information systems face?

Networked blood-management systems are vulnerable to ransomware that can freeze donor records and disrupt workflows. The U.S. HHS flagged blood centers as critical infrastructure in 2024, urging adoption of zero-trust architectures [15]. Read More

How are genotyping panels disrupting traditional serological crossmatching?

Multiplex genotyping identifies 300+ red-cell antigens from a single DNA sample, reducing alloimmunization risk in chronically transfused patients. Costs have fallen below USD 50 per panel, making routine use feasible in tertiary centers [21]. Read More

Which accreditation standards most influence purchasing decisions?

AABB accreditation and ISO 15189 certification drive procurement specifications in most markets. Analyzers lacking compatibility with these frameworks face exclusion from hospital tenders [4]. Read More

What role do public-private partnerships play in African blood-bank expansion?

The Global Fund and Gavi co-finance screening equipment procurement in 38 Sub-Saharan countries. These partnerships reduce per-unit screening costs by pooling reagent procurement across nations [16]. Read More

How will pathogen-reduction adoption affect screening reagent demand?

Broad-spectrum inactivation could eventually reduce the number of mandatory serological tests per unit. Near-term impact is limited because regulators still require parallel screening alongside inactivation [10]. Read More

What integration challenges arise when upgrading from manual to automated platforms?

Legacy LIS interfaces often lack HL7 FHIR compatibility, requiring middleware investment of USD 50,000–150,000 per site. Staff retraining typically adds 3–6 months before full throughput is achieved [9]. Read More

Blood Transfusion Diagnostics Market (2025 - 2035)

ID: MRFR/MED/0620-HCR

200 Pages

Nidhi Mandole

Last Updated: July 22, 2026

Blood Transfusion Diagnostics Market Size, Growth Research Report By Product Type (Infectious Disease Testing, Blood Grouping Tests, Compatibility Testing, Nucleic Acid Testing), By Technique (Enzyme-Linked Immunosorbent Assay, Polymerase Chain Reaction, Chemiluminescent Immunoassay, Microbiological Techniques), By End User (Hospitals, Blood Banks, Diagnostic Laboratories, Academic Institutions) - Competitor Industry Analysis and Trends Forecast Till 2035

Blood Transfusion Diagnostics Market

Market Size

Forecast Period2025-2035

CAGR (2025-2035)6.72%

2025 Market SizeUSD 6.52 Billion

2035 Market SizeUSD 12.49 Billion

Key Players

Grifols S.A.

Bio-Rad Laboratories

QuidelOrtho

Immucor

Quotient Limited

Beckman Coulter

Trends

Rising Surgical and Trauma Transfusion Volumes
Mandatory Individual-Donor NAT Regulations
Blood-Bank Automation and Digital Connectivity

Opportunities

Point-of-Care Blood-Typing Devices
AI-Driven Antibody Identification
Emerging-Market Blood-Bank Modernization

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Surgical and Trauma Transfusion Volumes | |
  2. 3.1.2 Mandatory Individual-Donor NAT Regulations | |
  3. 3.1.3 Blood-Bank Automation and Digital Connectivity | |
  4. 3.1.4 Expansion of Voluntary Blood-Donation Programs | |
  5. 3.1.5 Pathogen-Reduction Technology Adoption | |
  6. 3.1.6 Growth of Organ Transplant and Oncology Procedures | |
  7. 3.1.7 Point-of-Care and Rapid-Test Development |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Automated Platforms | |
  2. 3.2.2 Cold-Chain and Reagent Stability Challenges | |
  3. 3.2.3 Shortage of Trained Transfusion Technologists | |
  4. 3.2.4 Reimbursement Pressure on Blood-Bank Budgets | |
  5. 3.2.5 Regulatory Fragmentation Across Emerging Markets |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Point-of-Care Blood-Typing Devices | |
  2. 3.3.2 AI-Driven Antibody Identification | |
  3. 3.3.3 Emerging-Market Blood-Bank Modernization | |
  4. 3.3.4 Data Monetization Through Hemovigilance Platforms | |
  5. 3.3.5 Pathogen-Reduction as a Screening Alternative |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Blood Transfusion Diagnostics Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product Type | |
  1. 5.1.1 Instruments | |
  2. 5.1.2 Consumables |
2. 5.2 By Technology | |
  1. 5.2.1 Serology | |
  2. 5.2.2 Nucleic Acid Tests | |
  3. 5.2.3 Other Technologies |
3. 5.3 By Application | |
  1. 5.3.1 Disease Screening | |
  2. 5.3.2 Blood Group Typing |
4. 5.4 By End User | |
  1. 5.4.1 Hospitals | |
  2. 5.4.2 Diagnostic Laboratories | |
  3. 5.4.3 Other End Users
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Grifols S.A. | |
  2. 7.3.2 Bio-Rad Laboratories | |
  3. 7.3.3 QuidelOrtho | |
  4. 7.3.4 Immucor (Werfen) | |
  5. 7.3.5 Quotient Limited | |
  6. 7.3.6 Beckman Coulter (Danaher) | |
  7. 7.3.7 BAG Healthcare | |
  8. 7.3.8 DiaSorin S.p.A. | |
  9. 7.3.9 Hemosonics (Stago) | |
  10. 7.3.10 Agena Biosciences (Bruker)
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI and Machine-Learning Integration |
2. 8.2 Platform Consolidation and Reagent-Rental Economics |
3. 8.3 Molecular Typing and Extended Antigen Profiling |
4. 8.4 Sustainability and Green Blood Banking
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Blood Transfusion Diagnostics Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Blood Transfusion Diagnostics Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Market Driver Impact Analysis, 2026–2035 |
TABLE 4 Market Restraint Impact Analysis, 2026–2035 |
TABLE 5 Regional Market Summary — Blood Transfusion Diagnostics Market, 2025 |
TABLE 6 North America Blood Transfusion Diagnostics Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Blood Transfusion Diagnostics Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Blood Transfusion Diagnostics Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Blood Transfusion Diagnostics Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Blood Transfusion Diagnostics Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Blood Transfusion Diagnostics Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 12 Global Blood Transfusion Diagnostics Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 13 Global Blood Transfusion Diagnostics Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 14 Global Blood Transfusion Diagnostics Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix — Blood Transfusion Diagnostics Market, 2025 |
TABLE 16 Company Profiles — Key Players, Blood Transfusion Diagnostics Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 Report Scope & Methodology Summary |
TABLE 19 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Blood Transfusion Diagnostics Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Industry Value Chain Analysis — Blood Transfusion Diagnostics Market |
FIGURE 3 Porter's Five Forces Analysis — Blood Transfusion Diagnostics Market |
FIGURE 4 Global Blood Transfusion Diagnostics Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Blood Transfusion Diagnostics Market Share, by Product Type (2025) |
FIGURE 6 Blood Transfusion Diagnostics Market Share, by Technology (2025) |
FIGURE 7 Blood Transfusion Diagnostics Market Share, by Application (2025) |
FIGURE 8 Blood Transfusion Diagnostics Market Share, by End User (2025) |
FIGURE 9 Blood Transfusion Diagnostics Market Share, by Region (2025) |
FIGURE 10 Competitive Landscape Map — Blood Transfusion Diagnostics Market (2025)

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Product Type	Instruments, Consumables	Consumables	Instruments
Technology	Serology, Nucleic Acid Tests, Other Technologies	Serology	Nucleic Acid Tests
Application	Disease Screening, Blood Group Typing	Disease Screening	Blood Group Typing
End User	Hospitals, Diagnostic Laboratories, Other End Users	Hospitals	Other End Users

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Instruments	Hospitals replacing manual platforms with automated column-agglutination and solid-phase analyzers capable of 200+ samples per hour
Consumables	Recurring demand for gel cards, reagents, and NAT assay kits drives a stable revenue base across blood banks

Consumables remain the revenue backbone of the market due to the per-test procurement cycle inherent in transfusion diagnostics. Instruments are experiencing an accelerated refresh cycle as aging manual equipment reaches end-of-life.

By Technology

Sub-Segment	Key Trend
Serology	Gel-card and solid-phase automation sustaining dominant share in routine ABO/Rh typing and antibody screening
Nucleic Acid Tests	Regulatory mandates for individual-donor NAT screening driving rapid adoption for HIV, HBV, HCV, and emerging pathogens
Other Technologies	Molecular genotyping and microarray platforms expanding the testable antigen menu beyond serological limits

Serology underpins daily blood-bank operations globally, while nucleic acid testing captures incremental share as more countries transition from pooled to individual-donor screening protocols.

By Application

Sub-Segment	Key Trend
Disease Screening	Mandatory infectious-disease panels required for every donated blood unit prior to release
Blood Group Typing	Extended phenotyping and genotyping expanding the testing scope beyond basic ABO/Rh determination

Disease screening volumes are regulatory-floor driven, ensuring stable demand even during periods of reduced donation activity. Blood group typing is expanding as clinical protocols increasingly call for antigen-matched transfusions.

By End User

Sub-Segment	Key Trend
Hospitals	In-house blood banks and emergency departments performing the majority of bedside pre-transfusion testing
Diagnostic Laboratories	Centralized reference laboratories and national blood services processing highest per-site volumes
Other End Users	Military field hospitals, mobile collection units, and standalone blood centers adopting portable testing platforms

Hospitals dominate end-user spending due to the volume and urgency of pre-transfusion testing in surgical and trauma settings. Diagnostic laboratories lead in throughput per facility, while other end users represent the fastest-growing category as point-of-care devices mature.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”